Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo.
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D002460:Cell Line; D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic; D003606:Dacarbazine / Q000494:pharmacology*; D000939:Epitopes / Q000276:immunology; D005260:Female; D006183:H-2 Antigens / Q000276:immunology*; D007940:Leukemia L5178 / Q000276:immunology; D007942:Leukemia, Experimental / Q000276:immunology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008979:Moloney murine leukemia virus
D000951:Antigens, Neoplasm; D000939:Epitopes; D006183:H-2 Antigens; D003606:Dacarbazine